Ajanta Pharma Limited — Updates, 30-01-2026: General Updates
30-01-2026 | 03:22 pm
30-01-2026 | 03:22 pm
Ajanta Pharma's committee approved vesting 4,300 cash-settled Stock Appreciation Rights (SARs), ensuring no share dilution. Additionally, 800 employee stock options were cancelled, returning to the ESOP pool.
No comments yet. Be the first to comment!
